Agape ATP financials
$2.10−4.55%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 |
|---|---|---|---|
| Revenue | $1.5M | $1.3M | $1.4M |
| Gross profit | $838.3K | $759.1K | $936.6K |
| Gross margin | 55.0% | 57.4% | 65.4% |
| Operating income | -$3.3M | -$2.6M | -$2.1M |
| Net income | -$2.3M | -$2.5M | -$2.1M |
| Net margin | −149.6% | −186.8% | −146.9% |
| Diluted EPS | $-2.85 | $-31.74 | $-27.50 |
| EBITDA | -$3.2M | -$2.5M | -$2.1M |
| Operating cash flow | -$2.4M | -$2.7M | -$2.0M |
| Free cash flow | -$2.4M | -$2.8M | -$2.1M |
| Diluted shares | 0.8M | 0.1M | 0.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $89.7K | $2.0M | $4.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $54.9K | $137.0K | $79.6K |
| Total assets | $24.6M | $3.2M | $5.7M |
| Total liabilities | $2.2M | $1.3M | $1.4M |
| Shareholders' equity | $22.4M | $1.9M | $4.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology